As of December 2024, Wuhan Easy Diagnosis Biomedicine has a market cap of $631.23M. This makes Wuhan Easy Diagnosis Biomedicine the world's 10510th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $594.80M | -18.98% |
2023 | $734.15M | -59.89% |
2022 | $1.83B | -22.61% |
2021 | $2.37B | 64.34% |
2020 | $1.44B | 74.10% |
2019 | $826.65M | -17.93% |
2018 | $1.01B | - |